Zhang Kai, Zhang Yan-Qiong, Ai Wen-Bing, Hu Qing-Ting, Zhang Qiao-Juan, Wan Lin-Yan, Wang Xiao-Lian, Liu Chang-Bai, Wu Jiang-Feng
Kai Zhang, Yan-Qiong Zhang, Qing-Ting Hu, Qiao-Juan Zhang, Lin-Yan Wan, Xiao-Lian Wang, Chang-Bai Liu, Jiang-Feng Wu, Medical College, China Three Gorges University, Yichang 443002, Hubei Province, China.
World J Gastroenterol. 2015 Jan 21;21(3):878-87. doi: 10.3748/wjg.v21.i3.878.
To determine the role of Notch1 and Hes1 in regulating the activation of hepatic stellate cells (HSCs) and whether Hes1 is regulated by transforming growth factor (TGF)/bone morphogenetic protein (BMP) signaling.
Immunofluorescence staining was used to detect the expression of desmin, glial fibrillary acidic protein and the myofibroblastic marker α-smooth muscle actin (α-SMA) after freshly isolated, normal rat HSCs had been activated in culture for different numbers of days (0, 1, 3, 7 and 10 d). The expression of α-SMA, collagen1α2 (COL1α2), Notch receptors (Notch1-4), and the Notch target genes Hes1 and Hey1 were analyzed by reverse transcriptase-polymerase chain reaction. Luciferase reporter assays and Western blot were used to study the regulation of α-SMA, COL1α1, COL1α2 and Hes1 by NICD1, Hes1, CA-ALK3, and CA-ALK5 in HSC-T6 cells. Moreover, the effects of inhibiting Hes1 function in HSC-T6 cells using a Hes1 decoy were also investigated.
The expression of Notch1 and Hes1 mRNAs was significantly down-regulated during the culture of freshly isolated HSCs. In HSC-T6 cells, Notch1 inhibited the promoter activities of α-SMA, COL1α1 and COL1α2. On the other hand, Hes1 enhanced the promoter activities of α-SMA and COL1α2, and this effect could be blocked by inhibiting Hes1 function with a Hes1 decoy. Furthermore, co-transfection of pcDNA3-CA-ALK3 (BMP signaling activin receptor-like kinase 3) and pcDNA3.1-NICD1 further increased the expression of Hes1 compared with transfection of either vector alone in HSC-T6 cells, while pcDNA3-CA-ALK5 (TGF-β signaling activin receptor-like kinase 5) reduced the effect of NICD1 on Hes1 expression.
Selective interruption of Hes1 or maintenance of Hes1 at a reasonable level decreases the promoter activities of α-SMA and COL1α2, and these conditions may provide an anti-fibrotic strategy against hepatic fibrosis.
确定Notch1和Hes1在调节肝星状细胞(HSC)激活中的作用,以及Hes1是否受转化生长因子(TGF)/骨形态发生蛋白(BMP)信号通路调控。
采用免疫荧光染色法检测新鲜分离的正常大鼠HSC在培养不同天数(0、1、3、7和10天)后结蛋白、胶质纤维酸性蛋白和肌成纤维细胞标志物α-平滑肌肌动蛋白(α-SMA)的表达。通过逆转录-聚合酶链反应分析α-SMA、胶原蛋白1α2(COL1α2)、Notch受体(Notch1-4)以及Notch靶基因Hes1和Hey1的表达。利用荧光素酶报告基因检测和蛋白质印迹法研究NICD1、Hes1、组成型激活的ALK3(CA-ALK3)和组成型激活的ALK5(CA-ALK5)对HSC-T6细胞中α-SMA、COL1α1、COL1α2和Hes1的调控作用。此外,还研究了使用Hes1诱饵抑制HSC-T6细胞中Hes1功能的效果。
在新鲜分离的HSC培养过程中,Notch1和Hes1 mRNA的表达显著下调。在HSC-T6细胞中,Notch1抑制α-SMA、COL1α1和COL1α2的启动子活性。另一方面,Hes1增强α-SMA和COL1α2的启动子活性,且这种作用可通过用Hes1诱饵抑制Hes1功能来阻断。此外,与单独转染任一载体相比,在HSC-T6细胞中共转染pcDNA3-CA-ALK3(BMP信号通路激活素受体样激酶3)和pcDNA3.1-NICD1可进一步增加Hes1的表达,而pcDNA3-CA-ALK5(TGF-β信号通路激活素受体样激酶5)可降低NICD1对Hes1表达的影响。
选择性阻断Hes1或使Hes1维持在合理水平可降低α-SMA和COL1α2的启动子活性,这些情况可能为抗肝纤维化提供一种抗纤维化策略。